Literature DB >> 35341718

Substance use and misuse patterns and disability status in the 2020 US National Alcohol Survey: A contributing role for chronic pain.

Sharon Reif1, Katherine J Karriker-Jaffe2, Anne Valentine3, Deidre Patterson4, Amy A Mericle4, Rachel Sayko Adams5, Thomas K Greenfield4.   

Abstract

BACKGROUND: Evidence about substance use and misuse among adults with disabilities is still emerging, despite increased risk of chronic pain and mental health problems, which are in turn risk factors for substance use and misuse.
OBJECTIVE: We examined substance use and misuse among adults with selected self-reported disability (versus without), controlling for sociodemographics, depression/anxiety, physical health, and chronic pain, and assessed whether associations could be attributed to chronic pain.
METHODS: Data are from the nationally representative 2020 US National Alcohol Survey. Disability indicators included sensory or mobility impairment, receiving Medicare before age 65, and/or unemployment due to disability. Regression analyses determined associations of disability with past-year substance use and misuse. Mediation analyses examined the role of chronic pain.
RESULTS: Approximately 18% met 1+ disability criterion, representing 42.8 million adults. Disability was associated with reduced odds of current drinking (OR = 0.77, p < 0.01), but greater odds of daily nicotine use (OR = 1.43, p < 0.01), any drug use (OR = 1.32 p < 0.01), prescription drug misuse (OR = 1.99, p < 0.001), and other drug use (OR = 2.02, p < 0.001). Disability was not associated with high-intensity drinking or marijuana use. Chronic pain accounted for 17-38% of the association between disability and nicotine use, any drug use, prescription drug misuse, and other drug use.
CONCLUSIONS: Findings indicated higher rates of substance use and misuse among people with disabilities, accounting for depression/anxiety, physical health, and chronic pain, with pain being a significant mediator. Substance use screening, brief intervention, and treatment should include appropriate accommodations for disabilities, inclusive of comprehensive pain management options.
Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Alcohol; Disability; Drugs; Nicotine; Pain

Mesh:

Substances:

Year:  2022        PMID: 35341718      PMCID: PMC9232957          DOI: 10.1016/j.dhjo.2022.101290

Source DB:  PubMed          Journal:  Disabil Health J        ISSN: 1876-7583            Impact factor:   4.615


  30 in total

1.  Access to Pain Management as a Human Right.

Authors:  Frank Brennan; Diederik Lohman; Liz Gwyther
Journal:  Am J Public Health       Date:  2019-01       Impact factor: 9.308

Review 2.  Traumatic brain injury and substance misuse: a systematic review of prevalence and outcomes research (1994-2004).

Authors:  Beth L Parry-Jones; Frances L Vaughan; W Miles Cox
Journal:  Neuropsychol Rehabil       Date:  2006-10       Impact factor: 2.868

3.  Exploration of the association of selected pain diagnoses with risky alcohol use among active duty soldiers.

Authors:  Sharon Reif; Rachel Sayko Adams; Grant A Ritter; Mary Jo Larson
Journal:  Subst Abus       Date:  2019-10-22       Impact factor: 3.716

Review 4.  Substance abuse and psychosocial adaptation to physical disability: analysis of the literature and future directions.

Authors:  Susan Miller Smedema; Deborah Ebener
Journal:  Disabil Rehabil       Date:  2010       Impact factor: 3.033

5.  Ways of measuring drinking patterns and the difference they make: experience with graduated frequencies.

Authors:  T K Greenfield
Journal:  J Subst Abuse       Date:  2000

6.  The relationship between anxiety disorders and physical disorders in the U.S. National Comorbidity Survey.

Authors:  Jitender Sareen; Brian J Cox; Ian Clara; Gordon J G Asmundson
Journal:  Depress Anxiety       Date:  2005       Impact factor: 6.505

Review 7.  The level of evidence of medical marijuana use for treating disabilities: a scoping review.

Authors:  Nichole Stetten; Jamie Pomeranz; Michael Moorhouse; Ali Yurasek; Amy V Blue
Journal:  Disabil Rehabil       Date:  2018-11-20       Impact factor: 3.033

8.  State Legal Restrictions and Prescription-Opioid Use among Disabled Adults.

Authors:  Ellen Meara; Jill R Horwitz; Wilson Powell; Lynn McClelland; Weiping Zhou; A James O'Malley; Nancy E Morden
Journal:  N Engl J Med       Date:  2016-06-22       Impact factor: 91.245

9.  Prevalence of Disabilities and Health Care Access by Disability Status and Type Among Adults - United States, 2016.

Authors:  Catherine A Okoro; NaTasha D Hollis; Alissa C Cyrus; Shannon Griffin-Blake
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2018-08-17       Impact factor: 17.586

Review 10.  Effectiveness of brief alcohol interventions in primary care populations.

Authors:  Eileen Fs Kaner; Fiona R Beyer; Colin Muirhead; Fiona Campbell; Elizabeth D Pienaar; Nicolas Bertholet; Jean B Daeppen; John B Saunders; Bernard Burnand
Journal:  Cochrane Database Syst Rev       Date:  2018-02-24
View more
  4 in total

1.  Peer Support at the Intersection of Disability and Opioid (Mis)Use: Key Stakeholders Provide Essential Considerations.

Authors:  Joanne Nicholson; Anne Valentine; Emily Ledingham; Sharon Reif
Journal:  Int J Environ Res Public Health       Date:  2022-08-05       Impact factor: 4.614

2.  Longitudinal assessment of drinking changes during the pandemic: The 2021 COVID-19 follow-up study to the 2019 to 2020 National Alcohol Survey.

Authors:  William C Kerr; Yu Ye; Priscilla Martinez; Katherine J Karriker-Jaffe; Deidre Patterson; Thomas K Greenfield; Nina Mulia
Journal:  Alcohol Clin Exp Res       Date:  2022-06       Impact factor: 3.928

3.  Cancer Disparities Experienced by People with Disabilities.

Authors:  Rosemary B Hughes; Susan Robinson-Whelen; Carly Knudson
Journal:  Int J Environ Res Public Health       Date:  2022-07-27       Impact factor: 4.614

4.  Predictors of alcohol screening quality in a US general population sample and subgroups of heavy drinkers.

Authors:  Meenakshi S Subbaraman; Camillia K Lui; Katherine J Karriker-Jaffe; Thomas K Greenfield; Nina Mulia
Journal:  Prev Med Rep       Date:  2022-09-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.